3M ($MMM) announced the launch of its Tegaderm CHG intravenous port dressing, saying the device will help oncology patients receive injections comfortably and ward ...

ORLANDO, Fla.--(BUSINESS WIRE)--3M Critical and Chronic Care Solutions today announces the launch of its new 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Port Dressing, designed for patients with ...

ORLANDO - April 7, 2008 - 3M Health Care announced today that its newest member of its infection prevention platform, 3M™ Tegaderm™ CHG (chlorhexidine gluconate) IV Securement Dressing, demonstrated ...

3M Tegaderm CHG Chlorhexidine Gluconate IV Securement Dressing (3M). 3M’s Tegaderm CHG Chlorhexidine Gluconate IV Securement Dressing decreases catheter-related bloodstream infections and vascular ...

Tegaderm CHG I.V. Securement Dressing is only dressing fully compliant with updated CDC recommendation and INS Infusion Therapy Standards of Practice ST. PAUL, Minn.--(BUSINESS WIRE)--The Centers for ...

In the clinical trial, upon catheter removal, there were decreases noted in catheter colonization and skin colonization rates. 3M announced that the Food and Drug Administration (FDA) has approved an ...

Dubai, UAE, 29 October 2009 – 3M Health Care, a division of 3M, the innovative technology company that produces thousands of products for dozens of diverse industries, recently launched the first ...

The case for adopting the 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites is supported by the evidence. This technology allows observation, and provides ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Every IV catheter poses potential for serious and costly complications, including those occurring from commonly used peripheral intravenous (PIV) catheters. According ...

The company proposed that using the 3M Tegaderm CHG IV securement dressing (Tegaderm CHG) would not result in changes to the current care pathway or need additional resources. The External Assessment ...